Cerus, Grifols Extends INTERCEPT Blood System Distribution To Italy
Published: 26-May-2009
Cerus and Grifols have entered into an agreement to extend Grifols’ Intercept platelet and plasma distribution to Italy. The Intercept blood system inactivates a broad range of viruses, bacteria and parasites that may contaminate donated blood components, including emerging pathogens such as west nile virus, chikungunya and influenza virus.
Claes Glassell, President and CEO of Cerus, said: “we are pleased to broaden and further strengthen our relationship with Grifols, one of the largest pharmaceutical companies in Spain and the largest European plasma fractionator.”
“Building on our success to date, we look forward to working with Grifols in Italy to increase adoption of Intercept platelets and plasma,” he added.
Riccardo Vanni, Managing Director of Grifols Italia, said: “the Intercept technology perfectly complements Grifols’ transfusion line of products in Italy and is a good fit in terms of our marketing and sales organization.”
Network Sites

Suppliers To This Sector
Browse A-Z
Almac
Drug Development Solutions ...
STARLIMS
Benefits for Life Science Labs ...
Parenteral Drug Association (PDA)
Pharmaceutical Information and Education Services ...
Burkert Fluid Control Systems
Fluid and Gas Control Systems ...
IMCOR
LIMS and Laboratory Informatics Consultancy ...
Umicore Precious Metals Chemistry
Chemicals and Catalysts for Industrial Applications ...
White Papers
Browse A-Z
Water Treatment
From the control room to the downstream processing area and with an eye on utilities servi ...
A Vaccinne Bioassay Case Study – A Successful Strategic Outsourcing Model
Increasingly, pharma and biotech firms are searching for new drivers of revenue and profit ...
USB HotStart-IT for Real Time PCR
USB® Products from Affymetrix have a long-standing reputation in the life science marketpl ...
Enabling Drug Delivery Deal Making
Transdermal drug delivery: Time for a closer look. To find out more download this free whi ...
Automating Training Control Processes to Comply with FDA Requirements
Well-managed training programs minimize the risk of non-compliance and improve product qua ...
TNO Pharma Services: From Discovery to the Clinic
Our kinetics & metabolism experts can help you select and further develop your candidate d ...


Delicious
Digg
Reddit
Stumble
LinkedIn
Mail sent successfully